Cost-effectiveness of double reading versus single reading of mammograms in a breast cancer screening programme
Carles Lavila, Misericordia
MetadataShow full item record
Objectives: The usual practice in breast cancer screening programmes for mammogram interpretation is to perform double reading. However, little is known about its cost-effectiveness in the context of digital mammography. Our purpose was to evaluate the cost-effectiveness of double reading versus single reading of digital mammograms in a population-based breast cancer screening programme. Methods: Data from 28,636 screened women was used to establish a decision-tree model and to compare three strategies: 1) double reading; 2) double reading for women in their first participation and single reading for women in their subsequent participations; and 3) single reading. We calculated the incremental cost-effectiveness ratio (ICER), which was defined as the expected cost per one additionally detected cancer. We performed a deterministic sensitivity analysis to test the robustness of the ICER. Results: The detection rate of double reading (5.17‰) was similar to that of single reading (4.78‰; P = .768). The mean cost of each detected cancer was €8,912 for double reading and €8,287 for single reading. The ICER of double reading versus single reading was €16,684. The sensitivity analysis showed variations in the ICER according to the sensitivity of reading strategies. The strategy that combines double reading in first participation with single reading in subsequent participations was ruled out due to extended dominance. Conclusions: From our results, double reading appears not to be a cost-effective strategy in the context of digital mammography. Double reading would eventually be challenged in screening programmes, as single reading might entail important net savings without significantly changing the cancer detection rate. These results are not conclusive and should be confirmed in prospective studies that investigate long-term outcomes like quality adjusted life years (QALYs).
Is part ofPLoS ONE, 2016, vol. 11, núm. 7, e0159806
European research projects
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Vilaprinyo Terré, Ester; Forné Izquierdo, Carles; Carles Lavila, Misericordia; Sala i Serra, Maria; Pla Farnós, Roger; Castells, Xavier; Domingo, Laia; Rué i Monné, Montserrat; Interval Cancer Study Group (Public Library of Science, 2014)The one-size-fits-all paradigm in organized screening of breast cancer is shifting towards a personalized approach. The present study has two objectives: 1) To perform an economic evaluation and to assess the harm-benefit ...
Carles Lavila, Misericordia; Vilaprinyo Terré, Ester; Cots, Francesc; Gregori Gomis, Aleix; Pla Farnós, Roger; Román, Rubén; Sala i Serra, Maria; Macià, Francesc; Castells, Xavier; Rué i Monné, Montserrat (BioMed Central, 2011)Background: Breast cancer (BC) causes more deaths than any other cancer among women in Catalonia. Early detection has contributed to the observed decline in BC mortality. However, there is debate on the optimal screening ...
Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis Martínez Alonso, Montserrat; Carles Lavila, Misericordia; Pérez Lacasta, María José; Pons Rodríguez, Anna; Garcia, Montse; Rué i Monné, Montserrat (BMJ Publishing Group, 2017)The aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) and observational studies is to assess the effect of decision aids (DAs) in women aged 50 and below facing the decision to be ...